At a glance
ClinicalIndex Comparison RecordN/ACompleted· 100 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Biomarkers Plus Bioimpedance Vector Analysis to Predict Cardiorenal Syndrome Onset and Prognosis in Patients With Acutely Decompensated Heart Failure: Biomonitoring and Cardiorenal Syndrome in Heart Failure(BIONICS-HF) Trial
In Brief
An observational study for Cardiorenal Syndrome and Acute Decompensated Heart Failure. Completed, enrolled 100 participants across 2 sites in 2 countries.
Detailed Summary
The purpose of this study is to evaluate the ability of a non-invasive monitor that measures how much fluid is in the body as well as various blood tests for their ability to predict worsening kidney function in patients with heart failure.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesItaly, United States
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartMar 2012
First PostedApr 2012
Primary CompletionJul 2012
Study CompletionNov 2013
TodayJul 2026
First PostedApr 4, 2012
Enrollment StartMar 1, 2012
Primary CompletionJul 1, 2012
Study CompletionNov 1, 2013
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 14.2 years ago